Report cover image

Arsenal Medical Inc - Product Pipeline Analysis, 2026 Update

Publisher GlobalData
Published Apr 20, 2026
Length 37 Pages
SKU # GBDT21121719

Description

Summary

Arsenal Medical Inc (Arsenal Medical) is a clinical-stage company that creates biomaterials to solve challenging and underserved medical problems. The company develops materials designed to address unmet medical needs across various therapeutic areas. It offers NeoCast, an injectable material for neurovascular occlusion, and ResQFoam, a rapidly expanding foam for controlling hemorrhage in trauma cases. Arsenal Medical's products are utilized in medical applications such as treating neurovascular conditions and managing life-threatening abdominal trauma. The company's therapeutic areas include trauma, neurovascular, peripheral vascular and women health. Arsenal Medical is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Arsenal Medical Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

37 Pages
Arsenal Medical Inc Company Overview
Arsenal Medical Inc Company Snapshot
Arsenal Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
Arsenal Medical Inc – Pipeline Analysis Overview
Arsenal Medical Inc - Key Facts
Arsenal Medical Inc - Major Products and Services
Arsenal Medical Inc Pipeline Products by Development Stage
Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
Arsenal Medical Inc Pipeline Products Overview
AMI-004
AMI-004 Product Overview
Arsenal Foam System - Abdominal Aortic Aneurysm
Arsenal Foam System - Abdominal Aortic Aneurysm Product Overview
NeoCast
NeoCast Product Overview
NeoCast Clinical Trial
ResQFoam
ResQFoam Product Overview
ResQFoam Clinical Trial
Arsenal Medical Inc - Key Competitors
Arsenal Medical Inc - Key Employees
Arsenal Medical Inc - Locations And Subsidiaries
Head Office
Recent Developments
Arsenal Medical Inc, Recent Developments
Mar 04, 2026: Arsenal Medical Announces First Patient Treated with ResQFoam for Life-Threatening Abdominal Bleeding
Jul 16, 2025: Treatment with Next-Generation, Liquid Embolic NeoCast is Pain-Free and Leads to Rapid Resorption of Chronic Subdural Hematoma
Feb 06, 2025: Arsenal Medical Announces Complete Enrollment of the Initial Cohort in the EMBO-02 Study Assessing NeoCast for the Treatment of Chronic Subdural Hematoma
Jul 11, 2018: FDA approves clinical trial for potentially life-saving trauma foam
Jun 05, 2017: U.S. Food and Drug Administration Grants Arsenal Medical Investigational Device Exemption Approval to Conduct Clinical Study on ResQFoam Safety and Effectiveness
Dec 09, 2015: Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoam Trauma Product through Regulatory Approval
Jan 15, 2015: Arsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam Technology
Dec 10, 2012: Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II DARPA Contract
Dec 10, 2012: Arsenal Medical’s Foam Technology For Battlefield Injuries Receives $15.5m Phase II DARPA Contract
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Arsenal Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
Arsenal Medical Inc Pipeline Products by Equipment Type
Arsenal Medical Inc Pipeline Products by Indication
Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
Arsenal Medical Inc, Key Facts
Arsenal Medical Inc, Major Products and Services
Arsenal Medical Inc Number of Pipeline Products by Development Stage
Arsenal Medical Inc Pipeline Products Summary by Development Stage
Arsenal Medical Inc Ongoing Clinical Trials by Trial Status
Arsenal Medical Inc Ongoing Clinical Trials Summary
AMI-004 - Product Status
AMI-004 - Product Description
Arsenal Foam System - Abdominal Aortic Aneurysm - Product Status
Arsenal Foam System - Abdominal Aortic Aneurysm - Product Description
NeoCast - Product Status
NeoCast - Product Description
NeoCast - First in Human Feasibility Study of Pre-Surgical Embolisation of Hypervascular Extra-axial Brain Tumours with the Arsenal Medical Distal Penetrating Embolic System (DPE) to evaluate initial Safety and Performance
NeoCast - First in Human Study of the Safety and Feasibility of Middle Meningeal Artery (MMA) Embolisation with the Arsenal Medical NeoCast Embolic System for the Treatment of Chronic Subdural Hematoma (cSDH)
ResQFoam - Product Status
ResQFoam - Product Description
ResQFoam - Reducing Exsanguination via In-vivo Expandable Foam
Arsenal Medical Inc, Key Employees
Glossary
List of Figures
Arsenal Medical Inc Pipeline Products by Equipment Type
Arsenal Medical Inc Pipeline Products by Development Stage
Arsenal Medical Inc Ongoing Clinical Trials by Trial Status

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.